| Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis N Kakiuchi, K Yoshida, M Uchino, T Kihara, K Akaki, Y Inoue, K Kawada, ... Nature 577 (7789), 260-265, 2020 | 223 | 2020 |
| Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling Y Watatani, Y Sato, H Miyoshi, K Sakamoto, K Nishida, Y Gion, Y Nagata, ... Leukemia 33 (12), 2867-2883, 2019 | 211 | 2019 |
| Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas K Kataoka, H Miyoshi, S Sakata, A Dobashi, L Couronné, Y Kogure, ... Leukemia 33 (7), 1687-1699, 2019 | 146 | 2019 |
| Landscape and function of multiple mutations within individual oncogenes Y Saito, J Koya, M Araki, Y Kogure, S Shingaki, M Tabata, MB McClure, ... Nature 582 (7810), 95-99, 2020 | 111 | 2020 |
| Genetic alterations in adult T‐cell leukemia/lymphoma Y Kogure, K Kataoka Cancer science 108 (9), 1719-1725, 2017 | 80 | 2017 |
| Combined Cohesin–RUNX1 deficiency synergistically perturbs chromatin looping and causes myelodysplastic syndromes Y Ochi, A Kon, T Sakata, MM Nakagawa, N Nakazawa, M Kakuta, ... Cancer discovery 10 (6), 836-853, 2020 | 76 | 2020 |
| A comprehensive characterization of cis-acting splicing-associated variants in human cancer Y Shiraishi, K Kataoka, K Chiba, A Okada, Y Kogure, H Tanaka, S Ogawa, ... Genome research 28 (8), 1111-1125, 2018 | 75 | 2018 |
| Whole-genome landscape of adult T-cell leukemia/lymphoma Y Kogure, T Kameda, J Koya, M Yoshimitsu, K Nosaka, J Yasunaga, ... Blood, The Journal of the American Society of Hematology 139 (7), 967-982, 2022 | 67 | 2022 |
| LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells T Jo, M Nishikori, Y Kogure, H Arima, K Sasaki, Y Sasaki, T Nakagawa, ... Blood, The Journal of the American Society of Hematology 136 (6), 684-697, 2020 | 42 | 2020 |
| TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia K Akizuki, M Sekine, Y Kogure, T Kameda, K Shide, J Koya, A Kamiunten, ... BMC cancer 20, 1-8, 2020 | 24 | 2020 |
| Effect of active hexose-correlated compound in women receiving adjuvant chemotherapy for breast cancer: a retrospective study S Hangai, S Iwase, T Kawaguchi, Y Kogure, T Miyaji, T Matsunaga, ... The Journal of Alternative and Complementary Medicine 19 (11), 905-910, 2013 | 24 | 2013 |
| Single-cell analysis of the multicellular ecosystem in viral carcinogenesis by HTLV-1 J Koya, Y Saito, T Kameda, Y Kogure, M Yuasa, J Nagasaki, MB McClure, ... Blood cancer discovery 2 (5), 450-467, 2021 | 23 | 2021 |
| Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis Y Kogure, A Yoshimi, K Ueda, Y Nannya, M Ichikawa, F Nakamura, ... Annals of Hematology 94, 989-994, 2015 | 20 | 2015 |
| Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies S Fukuhara, Y Oshikawa‐Kumade, Y Kogure, S Shingaki, H Kariyazono, ... Cancer science 113 (8), 2763-2777, 2022 | 18 | 2022 |
| Pan-cancer comparative and integrative analyses of driver alterations using Japanese and international genomic databases S Horie, Y Saito, Y Kogure, K Mizuno, Y Ito, M Tabata, T Kanai, ... Cancer Discovery 14 (5), 786-803, 2024 | 16 | 2024 |
| Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma T Kameda, K Kataoka, A Kamiunten, M Hidaka, H Miyoshi, N Nakano, ... Haematologica 108 (8), 2178, 2023 | 10 | 2023 |
| Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy–driven Metabolic Reprogramming MB McClure, Y Kogure, N Ansari-Pour, Y Saito, HH Chao, J Shepherd, ... Cancer Research Communications 3 (2), 281-296, 2023 | 8 | 2023 |
| Common germline risk variants impact somatic alterations and clinical features across cancers S Namba, Y Saito, Y Kogure, T Masuda, ML Bondy, P Gharahkhani, ... Cancer Research 83 (1), 20-27, 2023 | 8 | 2023 |
| Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion J Ito, Y Nakano, H Shima, T Miwa, Y Kogure, K Isshiki, F Yamazaki, ... Brain tumor pathology 37, 105-110, 2020 | 8 | 2020 |
| ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone Y Kogure, H Handa, Y Ito, M Ri, Y Horigome, M Iino, Y Harazaki, ... Blood Journal, blood. 2023022540, 2024 | 7 | 2024 |
Keisuke KataokaDivision of Hematology, Department of Medicine, Keio University School of MedicineZweryfikowany adres z umin.ac.jp
